The ALRCaN Global webinar, titled “Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols,” is scheduled for Friday, February 27, 2026, at 09:00 AM ET.

Featuring Dr. Ira Kraft, the session will explore the comparative therapeutic outcomes for Adolescent and Young Adult (AYA) patients with Acute Myeloid Leukemia (AML) based on the clinical protocol used. Organized by Resonance Health and created by Ivana Cáceres, the event is supported by the leadership team of Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer. This discussion provides a vital platform for the global medical community to evaluate the nuances between adult and pediatric treatment frameworks and their specific impact on the AYA population.